Loading...
Loading...
Among the 4 tracked institutional investors we monitor, ICCC (IMMUCELL CORP) is held with a combined value of $3.17M across 508,667 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.86M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 2 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$3.17M
Total Shares Held
508,667
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.86M | 0.00% | New |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $960.82K | 0.00% | +0.7% |
| 3 | CITADEL ADVISORS LLC | $225.96K | 0.00% | -9.4% |
| 4 | BlackRock, Inc. | $115.12K | 0.00% | +11.9% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of ICCC with a position worth $1.86M, representing 0.00% of their portfolio. In total, 4 institutional investors hold ICCC with a combined value of $3.17M.
In the most recent quarter, 1 fund opened a new position in ICCC. Additionally, 2 increased their holdings and 1 reduced their positions.
Institutional investors hold $3.17M worth of ICCC stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $1.86M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ICCC, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ICCC positions.